Cohance Lifesciences Ltd (COHANCE) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003386, "name": "Cohance Life", "stock_name": "Cohance Life", "full_name": "Cohance Lifesciences Ltd", "name_url": "stocks-analysis/cohance-life", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "441.35", "chg": -1.35, "chgp": "-0.3%", "dir": -1, "prev_price": "442.70", "mcapval": "16,624.00 Cr", "mcap": "Small Cap", "scripcode": 543064, "symbol": "COHANCE", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE03QK01018", "curr_date": "Jul 17, 03:30 PM", "curr_time": "04:48 AM", "last_traded_at": "Jul 17, 03:30 PM IST", "bse_nse_vol": "40.92 lacs", "exc_status": "Active", "traded_date": "Jul 17, 2026", "traded_date_str": "2026 07 17", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/cohance-life-1003386-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Cohance Lifesciences Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-strong-sell-4096940", "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/CohanceLifescie_mojoScore_4096940.png", "date": "2026-07-11 10:10:32", "description": "Cohance Lifesciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 May 2026, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 11 July 2026, providing investors with the latest insights into its performance and valuation." }, { "title": "Cohance Lifesciences Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-strong-sell-4078698", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CohanceLifescie_mojoScore_4078698.png", "date": "2026-06-30 10:10:55", "description": "Cohance Lifesciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 May 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 30 June 2026, providing investors with the latest view of the company’s position in the market." }, { "title": "Cohance Lifesciences Gains 12.87%: 3 Key Factors Driving the Surge", "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-gains-1287-3-key-factors-driving-the-surge-4075165", "imagepath": "", "date": "2026-06-27 12:00:53", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>22 Jun:</strong> Stock opens at Rs.406.25 with modest gains</p>\n <p><strong>23 Jun:</strong> Intraday high and upper circuit hit at Rs.486.30</p>\n <p><strong>24 Jun:</strong> Continued gains with moderate volume</p>\n <p><strong>25 Jun:</strong> Slight profit booking closes week at Rs.457.95</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.405.75</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.457.95</div><div class=\"stat-chang..." }, { "title": "Cohance Lifesciences Ltd Locks at Upper Circuit With 16.13% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-surges-to-upper-circuit-on-robust-buying-pressure-4069159", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CohanceLifescie_stocks_hitting_upper_circuit_4069159.png", "date": "2026-06-23 12:00:13", "description": "At Rs 486.3, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Cohance Lifesciences Ltd locked at its upper circuit of 20% on 23 Jun 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Cohance Lifesciences Ltd Sees Surge in Value Trading Amid Volatility and Institutional Caution", "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-sees-surge-in-value-trading-amid-volatility-and-institutional-caution-4069118", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CohanceLifescie_most_active_equities_by_value_4069118.png", "date": "2026-06-23 11:00:11", "description": "Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable spike in trading activity on 23 June 2026, with total traded value nearing ₹499.6 crores and volume exceeding 1.11 crore shares. The stock outperformed its sector by 11.7% and reversed a four-day losing streak, signalling renewed investor interest despite its strong sell rating and recent downgrade by MarketsMOJO." }, { "title": "Cohance Lifesciences Ltd Surges 8.81% to Day's High of Rs 440.8 — Outperforms Sector by 6.14 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-ltd-hits-intraday-high-with-881-surge-on-23-jun-2026-4068819", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CohanceLifescie_priceRelatedfactors_4068819.png", "date": "2026-06-23 10:02:29", "description": "The Sensex edged up 0.10% on 23 Jun 2026, but Cohance Lifesciences Ltd surged 8.81%, outperforming its Pharmaceuticals & Biotechnology sector by 6.14 percentage points. This sharp single-session gain rewrites the short-term narrative for the small-cap stock, raising the question of whether this is a genuine breakout or a relief rally within a broader downtrend." }, { "title": "Cohance Lifesciences Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-strong-sell-4063096", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CohanceLifescie_mojoScore_4063096.png", "date": "2026-06-19 10:10:57", "description": "Cohance Lifesciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 19 June 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and technical outlook." }, { "title": "Cohance Lifesciences Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-strong-sell-4037300", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CohanceLifescie_mojoScore_4037300.png", "date": "2026-06-08 10:10:40", "description": "Cohance Lifesciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 May 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 08 June 2026, providing investors with the latest perspective on the company’s position." }, { "title": "Cohance Lifesciences Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/cohance-lifesciences-ltd-is-rated-strong-sell-4037317", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/CohanceLifescie_mojoScore_4037317.png", "date": "2026-06-07 10:10:33", "description": "Cohance Lifesciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date perspective on the company’s performance and outlook." } ], "total": 579, "sid": "1003386", "stock_news_url": "https://www.marketsmojo.com/news/cohance-lifesciences-1003386" }, "announcements": [ { "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018", "datetime": "07-Jul-2026", "details": "Compliance Certificate under 74(5) of SEBI (DP) Regulations 2018", "source": "BSE" }, { "caption": "Closure of Trading Window", "datetime": "26-Jun-2026", "details": "Closure of Trading Window", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "26-Jun-2026", "details": "Newspaper Publication", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Cohance Lifesciences Ltd has declared <strong>100%</strong> dividend, ex-date: 09 Sep 22", "dt": "2022-09-09", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Cohance Lifesciences Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 25 Sep 20", "dt": "2020-09-25", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

22 Jun: Stock opens at Rs.406.25 with modest gains

23 Jun: Intraday high and upper circuit hit at Rs.486.30

24 Jun: Continued gains with moderate volume

25 Jun: Slight profit booking closes week at Rs.457.95

Read full news article

Cohance Lifesciences Ltd Locks at Upper Circuit With 16.13% Gain — Buyers Queue, Sellers Absent

2026-06-23 12:00:13

At Rs 486.3, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Cohance Lifesciences Ltd locked at its upper circuit of 20% on 23 Jun 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Cohance Lifesciences Ltd Sees Surge in Value Trading Amid Volatility and Institutional Caution

2026-06-23 11:00:11

Cohance Lifesciences Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a remarkable spike in trading activity on 23 June 2026, with total traded value nearing ₹499.6 crores and volume exceeding 1.11 crore shares. The stock outperformed its sector by 11.7% and reversed a four-day losing streak, signalling renewed investor interest despite its strong sell rating and recent downgrade by MarketsMOJO.

Read full news article

Cohance Lifesciences Ltd Surges 8.81% to Day's High of Rs 440.8 — Outperforms Sector by 6.14 Percentage Points

2026-06-23 10:02:29

The Sensex edged up 0.10% on 23 Jun 2026, but Cohance Lifesciences Ltd surged 8.81%, outperforming its Pharmaceuticals & Biotechnology sector by 6.14 percentage points. This sharp single-session gain rewrites the short-term narrative for the small-cap stock, raising the question of whether this is a genuine breakout or a relief rally within a broader downtrend.

Read full news article

Cohance Lifesciences Ltd is Rated Strong Sell

2026-06-19 10:10:57

Cohance Lifesciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 19 June 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and technical outlook.

Read full news article

Cohance Lifesciences Ltd is Rated Strong Sell

2026-06-08 10:10:40

Cohance Lifesciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 14 May 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 08 June 2026, providing investors with the latest perspective on the company’s position.

Read full news article

Cohance Lifesciences Ltd is Rated Strong Sell

2026-06-07 10:10:33

Cohance Lifesciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article